ET
Healthcare & Life Sciences
EnLiven Therapeutics
EnLiven Therapeutics is a Healthcare & Life Sciences startup based in Israel, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About EnLiven Therapeutics
Based in Israel, EnLiven Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
EnLiven Therapeutics is a biopharmaceutical company developing novel therapeutics aimed at treating fibrotic diseases.
Explore EnLiven Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.